Spermosens AB Enters Into a Collaboration with Genea Fertility
Spermosens AB shared on LinkedIn:
“Spermosens enters into a collaboration with Australia-based Genea Fertility, which has more than 40 years of experience in fertility care and a national network of clinics, and plans to evaluate sperm-egg binding in infertility treatment at its clinics, subject to ethics approval.
This will be the first time an external clinic group evaluates JUNO-Checked, and we are very happy to work with Genea Fertility.
The study is an important step in our go-to-market strategy.
Building on our earlier clinical study, it adds clinical experience and strengthens the evidence for a predictive assessment that can help personalise and improve treatment.
In this study, JUNO-Checked will not be used to guide treatment decisions for any patient.
Thank you, Dean Morbeck and the team at Genea. We look forward to learning together.
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 11, 2026, 06:41Asima Ahmad: What Would Help Make Male Reproductive Health a More Routine Part of Care?
-
Nov 11, 2026, 06:34Ting Yuan: 42 and Hesitant About IVF – Respecting Patient Choice Without Losing Valuable Time
-
Nov 11, 2026, 06:25“Genetic Tests for Reproduction” Is Available in Spanish and Italian – ESHRE SIG Reproductive Genetics
-
Nov 11, 2026, 06:16Nicola Marconi: Honoured to Host the ESHRE-EBCOG Accreditation Team
-
Nov 11, 2026, 06:08Congratulations to Sahra Nathoo on Winning 1st Place for Best Video at ASRM 2026 – Twig Fertility
-
Nov 11, 2026, 06:01Vasiliki A. Moragianni: Looking Forward to Speaking at COGI Congress 2026
-
Nov 11, 2026, 05:48Khaled Abu Ali: Can We Warm Vitrified Blastocysts in a Single Step?
-
Nov 9, 2026, 18:08Strong Workplaces Start with Supported Employees – ESHRE
-
Nov 9, 2026, 18:00Nicole Haliday: Balancing Work and Fertility Treatment